Earlier this summer, the Health Authority – Abu Dhabi
(HAAD) announced changes to two of its main health insurance
programs, the 'Thiqa' plan and the Abu Dhabi Basic
Changes to 'Thiqa'
The Thiqa plan for Emiratis has seen the following changes:
Cardholders will receive 80% coverage of fees for treatment at
private hospitals; they will continue to receive 100% coverage for
treatment at Government hospitals;
Cardholders will receive 50% coverage of fees for treatment
'abroad' (the term abroad refers to treatment outside the
Emirate of Abu Dhabi and this includes other Emirates) unless the
treatment is unavailable in Abu Dhabi in which case they will
receive 100% coverage;
Changes have also been made to coverage for
'non-essential' treatments such as orthodontic braces for
adults and IVF treatment.
All prescriptions from private healthcare facilities will only
be dispensed at private pharmacies.
Abu Dhabi Basic Plan
The changes to the Abu Dhabi Basic Plan are more
significant. The Abu Dhabi Basic Plan is the plan offered to
expatriate workers, with a visa issued in Abu Dhabi and who earn
AED5,000/month or less.
Workers on this plan over 40 years of age could now be required
to pay 50% of their own premium if required to do so by their
employer and all employees will be obliged to pay 50% of the
premium for their dependants' coverage (wife and up to three
children). The cost of insurance for other dependants, such
as parents and fourth child, will also have to be fully borne by
the individual. Childbirth costs will also now be charged
according to a separate scheme.
Previously, the basic coverage was at an annual premium of AED
600, this has now increased to AED 800 for expatriate employees
between the ages of 18 to 59, and AED 5,500 for employees at the
age of 60 and above. Additionally, there is a mandatory maternity
surcharge for married females between the ages of 18 to 50 of AED
HAAD have announced that the changes for both plans came into
effect on 1 July 2016, however
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
The key pieces of legislation governing the authorisation, marketing, sale and supply of pharmaceutical products in Mauritius are the Pharmacy Act 1983 and the Consumer Protection (Price and Supplies Control) Act of 1998.
The development of Life Sciences has been one of Mauritius's long time ambitions. It is an industry which meshes well the island's ambitions in the pharmaceutical industry and bio-technological research.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).